Lascco
Company Team Projects Media Contact
         
 
 
NEWS

• 15.03.2017: Oral presentation of results from the CAL02-001 clinical trial at ECCMID 2017

• 09.08.2016: Combioxin escalates to high dose in CAL02-001 FIM clinical trial

• 23.03.2016: Combioxin announces first patient enrolled in CAL02 FIM clinical trial

• 12.01.2016: Combioxin receives Clinical Trial Authorisation for a first-in-man in patients

• 02.01.2015: Positive preclinical efficacy data for CAL02 published in Nature Biotechnology

 

 
 
IN THE MEDIA
 

• 15.02.2017: Discover Combioxin's CAL02 against bacterial resistance broadcasted on 3sat - Nano

• 04.11.2014: Une nouvelle voie pour lutter contre la résistance aux antibiotiques - Le Temps

• 29.10.2014 : Le long chemin vers la therapy - L'AGEFI

• 12.09.2014: Au-delà des antibiotiques - vaincre les résistances des bactérie - Le Temps


 

Lascco